Hepatitis C Virus
Data from Duke University Medical Center Provide New Insights into Hepatitis C Virus
Published in Hepatitis Weekly, May 9th, 2011
2011 MAY 9 -- New investigation results, 'Hepatitis C treatment among racial and ethnic groups in the IDEAL trial,' are detailed in a study published in Journal of Viral Hepatitis. "Previous studies of chronic hepatitis C virus (HCV) treatment have demonstrated variations in response among racial and ethnic groups including poorer efficacy rates among African American and Hispanic patients. The individualized dosing efficacy vs flat dosing to assess optimaL pegylated interferon therapy (IDEAL) trial enrolled 3070 patients from 118 United States centres to compare treatment with peginterferon (PEG-IFN) alfa-2a and ribavirin (RBV) and two doses of PEG-IFN alfa-2b and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2011-05-09)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Data from F. Curcio et al Provide New Insights into Hepatitis C Virus - Chronic Hepatitis C Virus
Findings from State University in Chronic Hepatitis C Virus Reported - Hepatitis B Virus
Investigators at University of California Publish New Data on Hepatitis B Virus - Hepatitis
New Findings Reported from G. Mondal and Co-Authors Describe Advances in Hepatitis - Hepatitis B Virus
New Hepatitis B Virus Research Reported from M. Bottecchia and Co-Authors - Hepatocellular Cancer
Reports Outline Hepatocellular Cancer Study Results from School of Medicine - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
